Skip to main content
logo
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.850
+0.070 (2.52%)
At close: Mar 27, 2026

HKG:1349 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7,3467,4696,6028,0577,76713,434
Market Cap Growth
2.74%13.14%-18.06%3.73%-42.18%-14.60%
Enterprise Value
6,1206,2655,4656,8506,42712,106
Last Close Price
2.852.782.442.393.163.42
PE Ratio
--156.1367.3249.7951.31
Forward PE
-22.4622.4622.4622.4622.46
PS Ratio
9.639.798.748.606.669.60
PB Ratio
2.922.972.693.103.055.00
P/TBV Ratio
3.013.062.783.223.135.20
P/FCF Ratio
----88.1373.56
P/OCF Ratio
---102.9841.5740.70
PEG Ratio
-0.690.690.690.690.69
EV/Sales Ratio
8.028.217.247.315.518.65
EV/EBITDA Ratio
--112.2848.1830.4145.55
EV/EBIT Ratio
---80.5949.8360.61
EV/FCF Ratio
----72.9266.29
Debt / Equity Ratio
0.010.010.010.010.060.01
Debt / EBITDA Ratio
--0.380.130.640.14
Debt / FCF Ratio
----1.600.21
Net Debt / Equity Ratio
-0.49-0.49-0.45-0.50-0.53-0.54
Net Debt / EBITDA Ratio
10.8210.82-22.64-9.13-6.39-5.44
Net Debt / FCF Ratio
--17.5042.17-15.32-7.91
Asset Turnover
--0.260.290.360.43
Inventory Turnover
--1.401.762.272.26
Quick Ratio
--6.083.602.983.56
Current Ratio
--6.403.703.073.65
Return on Equity (ROE)
-6.90%-6.90%1.69%4.70%6.18%10.12%
Return on Assets (ROA)
---0.18%1.65%2.48%3.85%
Return on Invested Capital (ROIC)
-13.44%-12.81%-0.63%6.89%11.02%19.48%
Return on Capital Employed (ROCE)
---0.30%3.30%5.00%7.20%
Earnings Yield
-2.38%-2.35%0.64%1.49%2.01%1.95%
FCF Yield
---0.95%-0.38%1.14%1.36%
Dividend Yield
2.39%-2.18%3.23%2.50%2.51%
Payout Ratio
--234.79%70.10%51.48%24.45%
Buyback Yield / Dilution
-1.26%-1.26%-0.23%-0.29%1.29%-5.59%
Total Shareholder Return
1.13%-1.26%1.95%2.94%3.80%-3.08%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.